Veronique Foutel - DBV Technologies Chief Strategic Marketing Officer

DBV Stock  EUR 1.34  0.01  0.78%   

Executive

Ms. Veronique Foutel has served as Director of Strategic Marketing of DBV Technologies SA since June 6, 2013. She gained experience of almost two decades in drug asset value identification, evaluation, creation, dissemination and confirmation through the tenure of diverse and complementary roles initially held within the French Health Authorities and later on in the Pharma Industry, mainly in the Pharma Division of Roche between 1996 and 2012 in Western Europe, in North America and at its Headquarters in Switzerland. She holds a Doctorate of Phylosophy degree in Pharmaceutical Sciences from Universite Paris V Rene Descartes and is a former hospital resident of Assistance Publique Hopitaux de Paris. since 2013.
Age 45
Tenure 11 years
Phone33 1 55 42 78 78
Webhttps://www.dbv-technologies.com

DBV Technologies Management Efficiency

The company has return on total asset (ROA) of (0.2178) % which means that it has lost $0.2178 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4299) %, meaning that it generated substantial loss on money invested by shareholders. DBV Technologies' management efficiency ratios could be used to measure how well DBV Technologies manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.48 M in total debt with debt to equity ratio (D/E) of 2.0, which is about average as compared to similar companies. DBV Technologies has a current ratio of 3.27, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist DBV Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, DBV Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DBV Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DBV to invest in growth at high rates of return. When we think about DBV Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 6 records

EXECUTIVE Age

Tom HousemanHighlight Communications AG
N/A
Franz WoodtliHighlight Communications AG
70
Kerstin LutzHighlight Communications AG
N/A
Olaf SchrderHighlight Communications AG
52
Hanns BeeseHighlight Communications AG
61
Lain DownieHighlight Communications AG
N/A
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. DBV Technologies S.A. was founded in 2002 and is headquartered in Montrouge, France. DBV Technologies operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 315 people. DBV Technologies SA (DBV) is traded on Frankfurt Exchange in Germany and employs 85 people.

Management Performance

DBV Technologies Leadership Team

Elected by the shareholders, the DBV Technologies' board of directors comprises two types of representatives: DBV Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DBV. The board's role is to monitor DBV Technologies' management team and ensure that shareholders' interests are well served. DBV Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DBV Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Pascale Ehouarn, Industrial Development and Production Director
Claude Thebault, Medical Director
Wence Agbotounou, Chief Clinical Trial Officer
Laurent Martin, Director of Regulatory Affairs
Viviane Monges, Director
Caroline Daniere, Chief Staff
Didier Hoch, Director
Daniel Tass, CEO Director
Hugh Sampson, Chief Scientific Officer
Pascal Wotling, Chief Officer
Charles Ruban, Chief Development Officer
Nathalie Donne, Director of Corporate Communication & Business Development
Lucie Mondoulet, Director of Research
Anne Pollak, Head Relations
Chahra Louafi, Director - Representative of CDC Entreprises (Innobio)
Peter Hutt, Independent Director
Michele Robertson, Chief Officer
Rafaele Tordjman, Director - Representative of Sofinnova Partners
Bertrand Dupont, Chief Technical Officer
Joseph Becker, VP Communications
Sbastien Robitaille, Chief Officer
Veronique Foutel, Chief Strategic Marketing Officer
Daniel Tasse, CEO
Rafale Tordjman, Director - Representative of Sofinnova Partners
Joan Schmidt, Executive Vice President General Counsel
George Horner, Director
Torbjorn Bjerke, Independent Director
Pharis Mohideen, Chief Medical Officer
PierreHenri Benhamou, Chairman of the Board, CEO
Torbjrn Bjerke, Independent Director
Mailys Ferrere, Director
Michel Rosen, Director
David Schilansky, CFO

DBV Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DBV Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards DBV Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, DBV Technologies' short interest history, or implied volatility extrapolated from DBV Technologies options trading.

Pair Trading with DBV Technologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DBV Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DBV Technologies will appreciate offsetting losses from the drop in the long position's value.

Moving together with DBV Stock

  0.66CSJA CSL LTD SPONADRPairCorr
  0.65CSJ CSL LimitedPairCorr

Moving against DBV Stock

  0.81MBG Mercedes-Benz GroupPairCorr
  0.75DBPE Xtrackers - LevDAXPairCorr
  0.68NOVA Novo Nordisk ASPairCorr
  0.62HX1A PT Hexindo AdiperkasaPairCorr
  0.61GQ9 SPDR Gold SharesPairCorr
The ability to find closely correlated positions to DBV Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DBV Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DBV Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DBV Technologies SA to buy it.
The correlation of DBV Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DBV Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DBV Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DBV Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DBV Technologies SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in DBV Stock please use our How to Invest in DBV Technologies guide.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for DBV Stock analysis

When running DBV Technologies' price analysis, check to measure DBV Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DBV Technologies is operating at the current time. Most of DBV Technologies' value examination focuses on studying past and present price action to predict the probability of DBV Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DBV Technologies' price. Additionally, you may evaluate how the addition of DBV Technologies to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Commodity Directory
Find actively traded commodities issued by global exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Please note, there is a significant difference between DBV Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if DBV Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DBV Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.